Chicago Atlantic BDC Reports Strong Q1 NII Growth Amidst Increased Unrealized Losses and Major Cannabis Rescheduling
LIEN is trading near its 52-week low of $8.92 (1.7% above the low) on light trading volume (0.3× avg).
Summary
Chicago Atlantic BDC reported strong Q1 earnings growth, but faced increased unrealized investment losses and higher debt. A significant cannabis regulatory change and a large shelf registration add complexity and potential dilution.
Key Events · Earnings and Guidance · LIEN
-
Strong Q1 Net Investment Income Growth
Net investment income per share increased to $0.44 for Q1 2026, up from $0.34 in Q1 2025. Total investment income rose to $16.7 million from $11.9 million year-over-year.
-
Increased Unrealized Depreciation
The company reported a net change in unrealized depreciation of $(1.43) million for Q1 2026, a significant worsening compared to $(0.034) million in Q1 2025.
-
Higher Debt Utilization and Reduced Liquidity
Outstanding borrowings on the revolving line of credit increased to $54.5 million as of March 31, 2026, from $25.0 million at December 31, 2025. Available credit decreased to $45.5 million from $75.0 million.
-
Major Cannabis Regulatory Shift
The U.S. Department of Justice ordered the reclassification of certain medical cannabis products from Schedule I to Schedule III, a significant policy change for the industry. A DEA hearing for adult-use cannabis is scheduled for June 29, 2026.
Analysis · LIEN · Unknown
Chicago Atlantic BDC reported a significant increase in net investment income (NII) per share and total investment income for Q1 2026, demonstrating strong operational performance. However, this was accompanied by a notable increase in net unrealized depreciation on investments. The company also substantially increased its outstanding borrowings on its revolving credit facility, reducing its available liquidity. A major development in the cannabis industry, the DOJ's reclassification of certain medical cannabis products from Schedule I to Schedule III, presents both opportunities for improved cash flows for affected borrowers and potential operational complexities and increased competition. Additionally, the company filed a shelf registration for up to $500 million in various securities, indicating a future capital raise that could be highly dilutive given the current market capitalization. The stock is currently trading near its 52-week low and at a significant discount to its net asset value, suggesting investor caution regarding these mixed signals and future dilution.
At the time of this filing, LIEN was trading at $9.07 on NASDAQ in the Unknown sector, with a market capitalization of approximately $207M. The 52-week trading range was $8.92 to $11.44. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.